ANSWER ENGINE IMPACT
Your Product Could Be Exactly What a Patient Needs Right Now. Does the Answer Engine Know That?
Right now, someone matching your product’s exact target profile – a patient, caregiver, or healthcare professional (HCP) – is seeking critical clinical direction. Increasingly, they aren’t turning to traditional search, they’re turning to answer engines: ChatGPT, Claude, Perplexity, Gemini, and specialised clinical AI models.
These platforms have become an active influence layer on treatment-seeking behaviour, sitting directly between people and clinical choices at key decision moments: diagnosis, therapy selection, escalation, and symptom management.
If an answer engine misrepresents, deprioritises, or ignores your product at that moment, what is it costing your bottom line?
The Scenario
Confident Clinical Authority Meets Unverified Synthesis
A patient reaches a defining inflection point: a fresh diagnosis, an HCP visit that raised more questions than answers, a current therapy that has failed, a chat with a friend or caregiver about new options.
When they consult an answer engine about it, it responds instantly with confident clinical authority even when the underlying data synthesis maybe incomplete or biased.
THE CRITICAL BLIND SPOT
Your therapy may be the optimal clinical choice for this scenario.
But did the model mention it?
Was it positioned accurately for this line of therapy?
Was it compared fairly against competitors - or deprioritised by an unverified assumption buried in the model's weights?
Answer engines already exert measurable influence over treatment decisions. Yet, most commercial and medical teams have low visibility into exactly how their brand is presented inside these private, high-stakes conversations.
Why This Matters
The Invisible Commercial Funnel
This is a new category of commercial risk and opportunity.
Every pharma team tracks traditional adoption levers: field engagement, payer access, evidence generation, KOL advocacy, and DTC campaigns. Answer engines now sit inside this exact funnel, influencing the moment an HCP, caregiver, or patient forms an opinion on what to do next.
Invisible Leakage: If your product is under-represented, you are losing share with no audit trail. It won’t appear in competitor intelligence, advisory boards, or field reports because it happens in an untracked dialogue with an LLM.
Friction-free Growth: When your clinical profile is favourably synthesised across realistic scenarios, you capture demand at zero marginal commercial cost.
The Competitor Advantage: Competitors may already be winning share here – not because their science is better, but because their clinical data is structured in a way language models prefer.
Why This Is Harder Than It Looks
The Exponential Math of Clinical Permutations
The initial instinct is simple: “Let’s just ask ChatGPT a few questions about our brand and see how it answers.” That assumption fundamentally underestimates the challenge.
Traditional search returns a static list of links. Answer engines synthesise a fresh, dynamic “clinical conversation” on demand, shaped by dozens of interacting variables. Auditing it requires navigating two layers of complexity:
1. There Is No Single "Patient Query"
A query prompted by a new diagnosis differs completely from a third-line inquiry from an HCP or a concerned caregiver. Your product must appear prominently in some scenarios, and not at all in others.
2. The Permutation Explosion
Consider this real-but-anonymised baseline clinical scenario:
“I am a 50-year-old male with moderate-to-severe atopic dermatitis. Topical steroids haven’t worked. I have uncontrollable itch disrupting my sleep, plus hypertension. I haven’t tried biologic therapy. What treatment is best?”
Vary the age, sex, comorbidities, prior therapies, or primary symptom, and that single baseline multiplies into over 4,500 clinically plausible variations.
Add different points of view (e.g. caregiver asking, HCP views, and alternative journey points, and a single indication routinely exceeds 15,000+ critical permutations – each representing a real decision-making moment.
Prioritisation Framework
Separating Critical Inflections from Background Noise
Auditing AI is not about tracking infinite prompts; it is about mapping the scenarios that most directly govern your commercial success. Every permutation falls into one of three strategic categories:
WHERE YOU MUST BE THE UNAMBIGUOUS CHOICE
Core indications and primary populations. If your therapy is not clearly and favourably positioned here, you face immediate, silent share loss.
WHERE YOU SHOULD APPEAR NEXT
Pipeline growth areas and emerging indications. Establishing strong, evidence-backed visibility here today secures future adoption.
WHERE YOU MUST NEVER APPEAR
Off-label or contraindicated profiles. Recommendations here present regulatory, compliance, and patient safety risks that must be flagged.
Strategic Analytics
From Raw Output to Actionable Sensitivity Analysis
Raw AI outputs e.g. “what was the answer to a hypothetical patient question” on their own offer little commercial value. The real intelligence comes from isolating the exact variables that cause an AI recommendation to shift.
This is clinical narrative sensitivity analysis conducted at scale:
What happens when patient age shifts from 45 to 65, with all else equal?
Did a phrasing nuance trigger an algorithmic assumption that overrode clinical evidence?
Does adding a common comorbidity cause the AI to favour a competitor?
These single-variable shifts provide the defensible link between a clinical communications fix and measurable share protection. Through iterative diagnostic loops, RED stresses the model’s logic to surface where competitors are quietly capturing preference.
Remediation Levers
What Does It Take to Change Future Answers?
Diagnosing the gap is step one. The essential commercial question is: What concrete actions will correct the AI’s clinical narrative moving forward?
| REMEDIATION LEVER | STRATEGIC IMPACT |
|---|---|
| 1. Comms Structuring | Re-architecting trial data, abstracts, and posters so AI engines parse them as primary, authoritative evidence. |
| 2. RAG Source Optimisation | Structuring digital medical assets and web portals so AI search crawlers ingest accurate data without friction. |
| 3. Evidence Gap Resolution | Identifying when model hesitation stems from missing RWE or head-to-head data, informing future Phase IV or HEOR planning. |
| 4. Scientific Framing | Refining the hierarchy and phrasing of your published claims so models interpret safety and efficacy data with clinical precision. |
RED aims to isolates the root causes behind every gap, providing an evidence-backed action plan tailored to specific patient populations and commercial decision points.
Medical Governance
AI Scaled by Technology. Governed by Medical Experts.
AI makes testing 15,000+ permutations possible; medical governance makes it trustworthy and defensible:
- Clinically Realistic Queries: Permutations reflect real patient presentations and HCP prescribing workflows.
- Nuanced Interpretation: Distinguishes outright hallucinations from subtle, clinically defensible alternatives.
- Defensible Signal Validation: Determines whether an AI hesitation stems from web indexing or a genuine evidence gap.
- MLR-Ready Outputs: Corrective actions align with strict Medical, Legal, and Regulatory standards.
RED draws directly on WPP’s dedicated healthcare network, leveraging the domain expertise of more than 2,000 medical and scientific professionals globally.
What You Actually Receive
A Guided Strategic Engagement, Not a Generic Dashboard
RED is a fully managed diagnostic engagement tailored to your therapy’s clinical profile, competitive landscape, and commercial forecast:
1
Tailored Query Universe
A validated matrix of thousands of patient/HCP scenarios covering your approved label and priority growth areas.
2
Multi-Platform AI Audit
Comprehensive testing across leading consumer and clinical answer engines.
3
Executive Intelligence Dashboard
Visual mapping of positioning, share of voice, and line-of-therapy alignment against key competitors.
4
Single-Variable Sensitivity Deep-Dives
Reporting on the specific clinical inflection points that trigger competitor recommendations.
5
Prioritised Remediation Roadmap
An MLR-aligned action plan across medical communications, publication strategy, and technical RAG optimisation.
6
Longitudinal Tracking (Optional)
Periodic re-testing to measure remediation impact and competitor shifts.
Market Comparison
Why Traditional AEO/GEO Tools Fall Short in Healthcare
| Dimension | Standard GEO Tools | Commercial Agency Audits | Medical Risk Audits | Recommendation Engine Diagnosis (RED) |
|---|---|---|---|---|
| Primary Objective | Track brand mentions & keyword SEO | Measure superficial sentiment & awareness | Detect safety issues and off-label risks | Identify & recover prescription share at risk, backed by clinical rigour |
| Query Depth & Scale | 10-100 generic marketing prompts | 50-200 static persona queries | Targeted, narrow compliance checks | 4,500-15,000+ clinically realistic, multi-variable permutations |
| Analytical Rigour | Binary: Mentioned vs. Not Mentioned | Qualitative sentiment and link review | Label & regulatory compliance checks | Iterative single-variable sensitivity analysis (isolating what flips the model) |
| Medical Governance | None; built for general commercial SEO | General marketing team review | High medical input, but strictly defensive | Deep medical & scientific oversight embedded throughout the engagement |
| Core Deliverable | SaaS dashboard access | One-off PowerPoint presentation | Compliance/Risk register | Prioritised, defensible strategic action roadmap |
| Question Answered | "Are we mentioned?" | "Do we look good?" | "Are we compliant?" | "What is this algorithmic gap costing us, and exactly how do we fix it?" |
Who Is RED For?
Commercial Brand Leads & P&L Owners: Uncover an invisible influence channel that is siphoning eligible patients and shaping market share.
Medical Affairs & Scientific Communications: Ensure published clinical evidence, trial endpoints, and indication nuances are synthesised accurately across AI platforms.
Digital Strategy & Commercial Excellence: Move beyond basic search marketing into rigorous, AI-native channel governance.
The Question You Can't Afford to Leave Unanswered
Answer engines are already sitting between your product and the people who need it.
Every day this channel goes unmeasured is a day your brand’s performance is shaped by algorithms you aren’t monitoring. The only question is whether your presence in this layer is actively guided by scientific strategy – or simply left to chance.
Four Things RED Delivers That Nothing Else Does:
- Quantifies Commercial Risk: Pinpoints situations which may cost you share, not vanity mentions.
- Unmatched Clinical Depth: Audits thousands of realistic patient permutations per indication.
- Diagnoses the "Why": Isolates the data points that trigger competitor preference.
- Medical-Grade Remediation: Action plans backed by evidence and healthcare experts.